Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
5961
-
5962
Patterns of lifetime use of substances by gender.
Published 2023“…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
-
5963
S1 Data -
Published 2023“…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
-
5964
Factors associated with substance use.
Published 2023“…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
-
5965
Factors associated with personality traits.
Published 2023“…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
-
5966
Expression levels of genes involved in glycolysis upon treatment with 10058-F4.
Published 2015“…<p>Expression levels of a set of genes (<i>GLUTI</i>, <i>HK</i>, <i>LDHA</i>, <i>MCT4</i>, <i>PDK1</i>, <i>PGK1</i>, and <i>PKM2</i>) were assessed by Q-PCR after the treatment of cells with 100 μM of 10058-F4 for 4 h. …”
-
5967
-
5968
-
5969
-
5970
Loss of <i>Tuba1a</i> leads to altered patterns of neurogenesis and migration.
Published 2019“…In comparison to wild-type cells at E14.5 (n = 4 wild-type and mutant embryos), the number of <i>Tuba1a</i> mutant total EdU+ cells are reduced (K), EdU-Ki67+ cells are increased (L), EdU+Ki67+ cells are increased (M) and the quit fraction (EdU+Ki67-/EdU+) is decreased (N). …”
-
5971
-
5972
S1 Graphical abstract -
Published 2024“…While the <i>amoA</i>-AOA: <i>amoA</i>-AOB ratio decreased from 9.8 in rainfed soils to 1.6 in soils irrigated for 100 years, indicating a favoring environment for AOB rather than AOA. …”
-
5973
-
5974
Table 1_Gamma knife radiosurgery for cerebral cavernous malformations: biologically effective dose predicts therapeutic outcomes.docx
Published 2025“…During follow-up, 13 patients (10.6%) experienced hemorrhage and AHR decreased from 13.6 to 4.3% per 100 lesion-years (IRR = 0.314; p < 0.001). …”
-
5975
-
5976
Q76A and F80A substitutions in Vpx disrupt ability of SIVmac 239 to transduce macrophages.
Published 2008“…<p>(A) Q76A and F80A substituted Vpx are efficiently incorporated into SIVmac virions. …”
-
5977
-
5978
Change of colocalization of Sig1R-YFP and KDEL-mRFP caused by (+)-pentazocine.
Published 2022“…Scale bar = 1 μm. A time-dependent decrease in spot coupling was observed between Sig1R-YFP and KDEL-mRFP after activation of Sig1R with 100 nM (+)-pentazocine (middle image). …”
-
5979
Table_1_Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant.docx
Published 2022“…The combined treatment increased the phosphorylation of eIF2α (P-eIF2α) relative to each drug alone and enhanced the decrease in cell survival. …”
-
5980
Table 1_Targeting nail psoriasis: IL-17A inhibitors demonstrate site-specific superiority over IL-23 inhibitor in a 24-week dermoscopy-guided real-world cohort.docx
Published 2025“…Objective<p>To compare the real-world clinical efficacy and safety of interleukin (IL)-17A inhibitors (secukinumab [SEC] and ixekizumab [IXE]) versus the IL-23 inhibitor guselkumab (GUS) in patients with nail psoriasis, with a focus on site-specific biologic therapeutic responses (nail matrix vs. nail bed) in a 24-week prospective observational cohort.…”